Site Announcement
For the latest results and update on CytoDyn’s Phase 2 CRC trial and more, here’s a link to our April 30, 2026 investor update webinar
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 12/13/19 | 8-K | Current report filing |
|
5 | |
| 12/10/19 | 424B5 | Prospectus filed pursuant to Rule 424(b)(5) |
|
58 | |
| 12/10/19 | 8-K | Current report filing |
|
4 | |
| 12/06/19 | 8-K | Current report filing |
|
3 | |
| 12/04/19 | SC 13D/A | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities |
|
5 | |
| 11/20/19 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 11/20/19 | 3 | Initial statement of beneficial ownership of securities |
|
2 | |
| 11/20/19 | 424B5 | Prospectus filed pursuant to Rule 424(b)(5) |
|
58 | |
| 11/20/19 | 8-K | Current report filing |
|
4 | |
| 11/19/19 | 8-K | Current report filing |
|
7 |
